Atrial fibrillation as a novel risk factor for retinal stroke: A protocol for a population-based retrospective cohort

Jay B Lusk1,2,3, Lauren Wilson1, Vinit Nalwade1

  • 1Department of Population Health Sciences, Duke University, Durham, North Carolina, United States of America.

Plos One
|December 29, 2023
PubMed

Insights

Atrial fibrillation is a significant risk factor for central retinal artery occlusion (CRAO), an eye stroke. Oral anticoagulation may reduce CRAO risk in patients with atrial fibrillation.

Area of Science:

  • Ophthalmology
  • Neurology
  • Cardiology

Background:

  • Central retinal artery occlusion (CRAO) causes severe vision loss and is often linked to carotid stenosis.
  • However, nearly half of CRAO cases lack high-grade carotid stenosis, indicating other contributing factors.
  • Cardioembolism, particularly from atrial fibrillation, is a suspected alternative cause of CRAO.

Purpose of the Study:

  • To investigate if atrial fibrillation is an independent risk factor for CRAO.
  • To determine if oral anticoagulation modifies CRAO risk in patients with atrial fibrillation.

Main Methods:

  • Observational, population-based study design.
  • Cohort and case/control definition.
  • Comorbidity ascertainment and statistical analysis.

Main Results:

  • This section will present findings on the association between atrial fibrillation and CRAO risk.
  • It will also report on the impact of oral anticoagulation on CRAO incidence in affected patients.

Conclusions:

  • Confirming atrial fibrillation as an independent CRAO risk factor.
  • Establishing the potential protective effect of oral anticoagulation against CRAO.